Establishes New Cardiac Remote Patient Monitoring Platform

建立新的心脏远程患者监测平台

DALLAS and NASHVILLE, Tenn., Jan. 4, 2024 /PRNewswire/ -- Pharos Capital Group, LLC ('Pharos'), a middle-market private equity firm based in Dallas and Nashville, and RhythMedix (or the 'Company'), a leading manufacturer and provider of remote cardiac monitoring systems and related services, jointly announced Pharos' acquisition of a majority stake in the Company.

田纳西州达拉斯和纳什维尔，2024年1月4日/PRNewswire/--Pharos Capital Group，LLC（“Pharos”），一家总部位于达拉斯和纳什维尔的中等市场私人股本公司，以及远程心脏监测系统和相关服务的领先制造商和提供商RhythMedix（或“公司”），共同宣布Pharos收购该公司的多数股权。

RhythMedix's existing management team is reinvesting alongside Pharos and will remain with the Company in their current roles. Dan Delaney, former CEO of TechLab, a previous Pharos portfolio company, will represent Pharos on the Board of RhythMedix. Terms of the transaction were not disclosed..

RhythMedix现有的管理团队正在与Pharos一起进行再投资，并将继续留在公司担任目前的角色。丹·德莱尼（DanDelaney）是前Pharos投资组合公司TechLab的前首席执行官，将代表Pharos加入RhythMedix董事会。交易条款未披露。。

Based in Mt. Laurel, NJ, RhythMedix was founded in 2013 to improve the remote cardiac monitoring experience for both patients and clinicians. The Company's proprietary RhythmStar® is the first wearable cardiac ECG monitor with built-in 4G cellular connection, providing faster, more comfortable, and overall better arrhythmia detection without the need for additional devices..

RhythMedix成立于2013年，总部位于新泽西州的劳雷尔山，旨在改善患者和临床医生的远程心脏监测体验。该公司专有的Rhythstar®是首款内置4G蜂窝连接的可穿戴式心脏心电监护仪，无需额外设备即可提供更快、更舒适、整体更好的心律失常检测。。

Joel Goldberg, a Partner at Pharos, said, 'We are impressed with RhythMedix's continued focus on driving innovation in the cardiac monitoring market, as evidenced by the RhythmStar platform's ability to give providers near real-time notifications, which allow for life-changing interventions for patients suffering from an event, while also lowering the cost of care by reducing unnecessary hospital admissions for patients who show no abnormalities.

Pharos合伙人乔尔·戈德伯格（JoelGoldberg）表示，“RhythMedix持续专注于推动心脏监测市场的创新，这给我们留下了深刻印象，Rhythstar平台能够向供应商提供近乎实时的通知，从而为患有事件的患者提供改变生活的干预，同时通过减少没有异常的患者不必要的住院来降低护理成本。

Pharos sees attractive opportunities to grow the Company both organically and through acquisitions, and we look forward to working with RhythMedix's esteemed co-founders, Brian Pike and Stan Biletsky, to continue providing convenient, cost-effective care to people across the country.'.

Pharos看到了公司有机发展和收购的诱人机会，我们期待着与RhythMedix备受尊敬的联合创始人Brian Pike和Stan Biletsky合作，继续为全国人民提供方便、经济高效的护理。”。

RhythMedix CEO Mr. Pike noted, 'We are pleased to partner with Pharos, a firm with a demonstrated track record of success and an exclusive focus on providing access to affordable healthcare while simultaneously improving patient outcomes. With its support, RhythMedix becomes a stronger, more capable company that will achieve higher growth by capturing additional market share, increasing R&D efforts, and expanding into adjacent remote patient monitoring modalities.

RhythMedix首席执行官派克指出，“我们很高兴与Pharos合作，Pharos是一家取得成功的公司，专注于提供负担得起的医疗服务，同时改善患者预后。在它的支持下，RhythMedix成为一家更强大、更有能力的公司，将通过占领更多的市场份额、加大研发力度以及扩展到邻近的远程患者监测模式来实现更高的增长。

The combination of Pharos' financial and industry expertise and our advanced technology positions RhythMedix to become an industry stalwart in the remote patient monitoring market.'.

Pharos的金融和行业专业知识以及我们的先进技术相结合，使RhythMedix成为远程患者监护市场的行业中坚力量。”。

This marks the sixth investment from Pharos' latest flagship fund, Pharos Capital Partners IV, L.P., investing alongside its parallel fund, Pharos Capital Partners IV-A, L.P., a licensed Rural Business Investment Company. The funds will continue Pharos' mission of promoting value-based care by lowering costs, improving outcomes, and expanding access, particularly within underserved communities..

这是Pharos最新旗舰基金Pharos Capital Partners IV，L.P.与其平行基金Pharos Capital Partners IV-A，L.P.共同投资的第六笔投资，Pharos Capital Partners IV-A，L.P.是一家获得许可的农村商业投资公司。这些基金将继续Pharos的使命，通过降低成本、改善结果和扩大获取途径，特别是在服务不足的社区内，促进基于价值的护理。。

About RhythMedixRhythMedix®, a medical device manufacturer and wireless medical technology company, provides innovative technology to transform the cardiac monitoring industry and improve patient outcomes. RhythmStar® is the first wearable cardiac monitor with built-in cellular connectivity, allowing physicians and their patients to remain continuously and comfortably connected for faster arrhythmia detection.

关于Rhydromedix®，一家医疗设备制造商和无线医疗技术公司，提供创新技术来改变心脏监护行业并改善患者预后。Rhythstar®是第一款内置细胞连接的可穿戴式心脏监护仪，允许医生和患者保持连续舒适的连接，以更快地检测心律失常。

Powerful proprietary algorithms alongside the RhythMedix Independent Diagnostic Testing Facility (IDTF) evaluate every heartbeat providing actionable reporting for healthcare providers. Learn more at www.rhythmedix.com..

强大的专有算法与RhythMedix独立诊断测试设施（IDTF）一起评估每个心跳，为医疗保健提供者提供可行的报告。更多信息，请访问www.rhythedix.com。。

About Pharos Capital GroupBased in Dallas and Nashville, Pharos Capital Group is a physician-founded investment firm focused on growing healthcare companies that aim to lower the total cost of care, improve patient outcomes and expand access to care in underserved markets. Since inception, Pharos has invested in 59 companies and has $1 billion of private equity assets under management as of September 30, 2023.

关于Pharos Capital Group总部位于达拉斯和纳什维尔，Pharos Capital Group是一家由医生创建的投资公司，专注于不断发展的医疗保健公司，旨在降低护理总成本，改善患者预后，并扩大服务不足市场的护理机会。自成立以来，截至2023年9月30日，Pharos已投资59家公司，管理着10亿美元的私人股本资产。

Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations, predominantly across healthcare sectors. For more information on Pharos, please visit www.pharosfunds.com or visit us on LinkedIn at https://www.linkedin.com/company/pharos-capital-group.

Pharos通常会向快速增长的中等市场公司投资2500万至5000万美元，寻求后期资金，用于内部增长、收购、杠杆收购、管理层收购或资本重组，主要用于医疗保健行业。有关Pharos的更多信息，请访问www.pharosfunds.com或访问我们的LinkedInhttps://www.linkedin.com/company/pharos-capital-group.

.

.

Media Contact: Caroline Luz203-570-6462[email protected]

媒体联系人：Caroline Luz203-570-6462[受电子邮件保护]

SOURCE Pharos Capital Group

来源Pharos Capital Group